Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2 × ACTH Syndrome, Ectopic × Metyrapone × Clear all

Phase

Status

Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Cushing Syndrome 2 Adrenal Hyperplasia, Congenital 2 ACTH Syndrome, Ectopic 2

Interventions

relacorilant 2 Metyrapone 2 pasireotide 1 Osilodrostat 1 ASP3662 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06106295 2025-09-22

Metyrapone for Mild Autonomous Cortisol Secretion (MACS)

Mayo Clinic

Phase 2 Active not recruiting

ACTH Syndrome, Ectopic, Adrenal Hyperplasia, Congenital, Cushing Syndrome

NCT07138274 2025-08-22

Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS

Mayo Clinic

Phase 2 Not yet recruiting

ACTH Syndrome, Ectopic, Adrenal Hyperplasia, Congenital, Cushing Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡